Mitelos advises two European companies in its internationalization process

Barcelona, February 13th, 2015.-  Mitelos is pleased to announce that it has acted as advisor to one of the leading European laboratories within the areas of fertility, gynaecology and endocrinology to expand its business towards Latin America.

This Company, dedicated to the research, development and distribution of innovative Medical Devices and Functional Dietary Supplements, is already exporting its products to more than 20 countries. Thanks to this agreement intermediated by Mitelos, it will increase its presence in America and reach the market of Paraguay for the first time, reinforcing its expansion strategy. The partner selected was founded 40 years ago and is one of the main local market players in Paraguay, not only in human health but also within the veterinary healthcare market.

Last year, the Paraguayan pharmaceutical market was worth some Eur 1.2 billion. Preliminary reports of the World Bank show a GDP growth estimated at 4.5% to 5% for 2014, and predicts an average of 4.5% for 2015.

This agreement must be added to the one recently signed in the field of self-care between an Italian company and the Spanish affiliate of an outstanding multinational, also under the advisory of Mitelos. The deal means an important jump in terms of quality and quantity within the expansion strategy of both parties by reinforcing its presence in the OTC Spanish market. Last year, this market reached some Eur 5 billion.


About Mitelos

Mitelos is a private and independent pharmaceutical company and business development services provider based in Barcelona, Spain, that develops, registers and licenses its own health products in addition to advise its clients to reach their growth goals.

For more information, contact:
Joaquim Colomé; tel: +34 937 063 611